Document Detail


Risperidone-induced acromegaly: a case report.
MedLine Citation:
PMID:  23983960     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Today, considering their adverse side effects, the first-generation antipsychotics have been replaced by the new-generation antipsychotics (also known as second-generation antipsychotic agents). The superiority of new-generation antipsychotics compared with first-generation antipsychotic agents in terms of side effects, especially movement disorders, are acknowledged by clinicians. But in recent years during the use of second-generation antipsychotic agents, endocrine side effects have been noteworthy. In our study with a diagnosis of paranoid schizophrenia treated with risperidone for 14 years and operated with the diagnosis of pituitary macroadenoma, a 32-year-old female patient is presented in the light of the literature examining the framework of the history of disease.
Authors:
Ayşe Koroglu; Cicek Hocaoglu
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic advances in psychopharmacology     Volume:  2     ISSN:  2045-1253     ISO Abbreviation:  Ther Adv Psychopharmacol     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2013-08-28     Completed Date:  2013-08-28     Revised Date:  2013-08-30    
Medline Journal Info:
Nlm Unique ID:  101555693     Medline TA:  Ther Adv Psychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  85-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic...
Next Document:  Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.